Favorable hormonal effects also seen.
-
-
Metformin improved some metabolic parameters and clinical outcomes.
-
Report elicits great interest from clinicians, endocrinologists and toxicologists.
-
Visto il diffuso uso del trattamento anche in persone senza ipogonadismo, uno studio ha analizzato il rischio a breve termine di tromboembolia venosa dovuta all'ormone.
-
The restrictions are being introduced after a safety review found that high-dose cyproterone medicines may increase risk for meningioma.
-
Bisphenols are known endocrine disruptors.
-
The link between metabolic syndrome and shift work.
-
Multidisciplinary care in this population is required.
-
Maternal obesity is a modifiable risk factor.
-
Lo studio Dayton evidenzia una riduzione del 39% dell’incidenza di tumore mammario.
-
Data on the prevalence and type of endocrine disorders are limited in this patient group.
-
Cardiac autonomic dysfunction is associated with psychiatric, cardiovascular conditions and mortality.
-
The specific effects of testosterone therapy have not been well studied in this population.
-
Cochrane analysis finds only 2 trials with reliable data.